netropsin has been researched along with melphalan in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gottikh, BP; Grokhovskiĭ, SL; Zhuze, AL | 1 |
| Belehradek, J; Mir, LM; Orlowski, S; Paoletti, C | 1 |
| Bielawska, A; Bielawski, K; Miltyk, W; Pałka, J; Sosnowska, K; Winnicka, K | 1 |
3 other study(ies) available for netropsin and melphalan
| Article | Year |
|---|---|
[Ligands possessing affinity to specific DNA base pair sequences. IX. Synthesis of netropsin and distamycin A analogs having sarcolysin residues or a platinum(II) atom].
Topics: Base Composition; Cisplatin; Distamycins; DNA; Ligands; Melphalan; Netropsin; Platinum | 1992 |
Transient electropermeabilization of cells in culture. Increase of the cytotoxicity of anticancer drugs.
Topics: Animals; Antineoplastic Agents; Bleomycin; Cell Membrane Permeability; Cell Survival; Cells, Cultured; Dactinomycin; Dose-Response Relationship, Drug; Drug Resistance; Electroshock; In Vitro Techniques; Melphalan; Methotrexate; Mice; Netropsin | 1988 |
Novel amidine analogue of melphalan as a specific multifunctional inhibitor of growth and metabolism of human breast cancer cells.
Topics: Amidines; Animals; Antineoplastic Agents, Alkylating; Blotting, Western; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Collagen; Dipeptidases; Distamycins; DNA Topoisomerases, Type I; DNA, Superhelical; Dose-Response Relationship, Drug; Humans; Integrin beta1; Melphalan; Molecular Structure; Netropsin; Receptor, IGF Type 1; Thymidine; Topoisomerase I Inhibitors | 2006 |